W V R Vieweg1, A B Sood, A Pandurangi, J J Silverman. 1. Department of Psychiatry, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23238-5414, USA. wieweg@vcu.edu
Abstract
OBJECTIVE: Antipsychotic drugs may contribute to weight gain in children and adolescents. METHOD: We used Medline's PubMed in the pediatric age using key words 'weight gain' and 'obesity', for each newer antipsychotic drug. RESULTS: We found 21 articles linking weight gain and obesity with newer antipsychotic drugs among youths. Risperidone was the most commonly cited agent. Weight gain from olanzapine was the largest among the more commonly prescribed newer agents. All studies reported absolute weight gain. Only a few studies used the better measure of body mass index (BMI). None incorporated growth charts to allow for changes in weight and height over time because of growth. CONCLUSION: Weight gain may be a major problem when prescribing newer antipsychotic drugs in the pediatric population. Risperidone is associated with less weight gain than olanzapine. Published reports and studies have not utilized state-of-the-art techniques using BMI with readily available growth charts. Copyright (c) Blackwell Munksgaard 2004
OBJECTIVE: Antipsychotic drugs may contribute to weight gain in children and adolescents. METHOD: We used Medline's PubMed in the pediatric age using key words 'weight gain' and 'obesity', for each newer antipsychotic drug. RESULTS: We found 21 articles linking weight gain and obesity with newer antipsychotic drugs among youths. Risperidone was the most commonly cited agent. Weight gain from olanzapine was the largest among the more commonly prescribed newer agents. All studies reported absolute weight gain. Only a few studies used the better measure of body mass index (BMI). None incorporated growth charts to allow for changes in weight and height over time because of growth. CONCLUSION:Weight gain may be a major problem when prescribing newer antipsychotic drugs in the pediatric population. Risperidone is associated with less weight gain than olanzapine. Published reports and studies have not utilized state-of-the-art techniques using BMI with readily available growth charts. Copyright (c) Blackwell Munksgaard 2004
Authors: Jean-Louis Goëb; Sophie Marco; Alain Duhamel; Renaud Jardri; Geraldine Kechid; Régis Bordet; Pierre Delion; Pierre Thomas Journal: Prim Care Companion J Clin Psychiatry Date: 2008
Authors: Andrea Lynn Murphy; David Martin Gardner; Steve Kisely; Charmaine Cooke; Stanley Paul Kutcher; Jean Hughes Journal: ISRN Obes Date: 2013-11-20